Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Foxp3 plays a key role in CD4 + CD25 + T reg cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4 + T cell activation by plate‐bound anti‐CD3 Ab as well as the relationship between its expression and regulatory function at the single‐cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4 + CD25 – cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4 + CD25 ++ T reg cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T reg cells. See accompanying commentary http://dx.doi.org/10.1002/eji.200636929
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, stimulation with immobilized CD3 mAb is known to increase FoxP3 expression that is strongly associated with hypo-responsiveness by activated CD4+ T-cells and is not directly correlated with suppressive capability 37 . It is, therefore, likely that this is also the case with TGN1412 in the solid phase assay since both TGN1412 and muromonab-CD3 stimulate a similar cytokine response.”
From Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release (2013) · cites this paper as [37]
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [386]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Cited by
Items 601–700 of 1,000
Elevated level of circulating CD4+Helios+FoxP3+cells in primary Sjogren’s syndrome patients
Liu, C., Guan, Z., Zhao, L., Song, Y., & Wang, H. (2016) · Modern Rheumatology · doi:10.1080/14397595.2016.1226470 · Cited by 24
Miguel, A., Sendra, L., Noé, V., Ciudad, C. J., Dasí, F., Hervás, D., Herrero, M. J., & Aliño, S. F. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s104393 · Cited by 24
Koster, B. D., Santegoets, S. J. A. M., Harting, J., Baars, A., van Ham, S. M., Scheper, R. J., Hooijberg, E., de Gruijl, T. D., & van den Eertwegh, A. J. M. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02320-0 · Cited by 23
Immune Dysregulation in Primary Immunodeficiency Disorders
Torgerson, T. R. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.02.002 · Cited by 22
Nair, V. S., Toor, S. M., Taouk, G. M., Pfister, G., Ouararhni, K., Alajez, N. M., & Elkord, E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900575 · Cited by 23
Tyagi, R. K., Jacobse, J., Li, J., Allaman, M. M., Otipoby, K. L., Sampson, E. R., Wilson, K. T., & Goettel, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630204 · Cited by 23
“Given that effector CD4 T cells in humans can upregulate FOXP3 upon activation (38, 39), the true identity of these cells is presently unclear.”
BackgroundTCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity
Lozano, T., Conde, E., Martín-Otal, C., Navarro, F. C., Lasarte-Cía, A., Nasrallah, R., Alignani, D., Gorraiz, M., Sarobe, P., Romero, J. P., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.030 · Cited by 24
Regulatory T cells hamper the efficacy of T-cell-engaging bispecific antibody therapy
Casey, M., Lee, C., Kwok, W. Y., Law, S. C., Corvino, D., Gandhi, M. K., Harrison, S. J., & Nakamura, K. (2023) · Haematologica · doi:10.3324/haematol.2023.283758 · Cited by 26
Ma, Y., Zhou, Y.-L., Yue, C., Zhang, G., Deng, L., Xie, G., Xu, W., & Shen, L. (2015) · Journal of Immunology Research · doi:10.1155/2015/547697 · Cited by 22
Singh, A. M., Dahlberg, P. E., Burmeister, K. A., Evans, M. D., Gangnon, R. E., Roberg, K. A., Tisler, C. J., DaSilva, D. F., Pappas, T., Salazar, L. E. P., et al. (2013) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-11-1 · Cited by 22
Zhao, X., Ye, F., Chen, L., Lü, W., & Xie, X. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01286.x · Cited by 21
Elkord, E., Burt, D. J., Drijfhout, J. W., Hawkins, R. E., & Stern, P. L. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0419-8 · Cited by 22
“For example, induction of FOXP3 expression conferred a regulatory activity in stimulated human CD4+CD25¡ T cells [39], and TGF-beta induced a regulatory activity in CD4+CD25¡ T cells through the induction of FOXP3 expression [40], while other reports showed that the induction of FOXP3 did not correlate with Treg chara…”
BackgroundFOXP3 protects conventional human T cells from premature restimulation-induced cell death
Voss, K., Lake, C., Luthers, C. R., Lott, N. M., Dorjbal, B., Arjunaraja, S., Bauman, B. M., Soltis, A. R., Sukumar, G., Dalgard, C. L., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0316-z · Cited by 21
2025 Inborn errors of immunity practice parameter
Orange, J. S., Chinen, J., Horner, C. C., Kobrynski, L. J., Ballow, M. C., Butte, M. J., Chandrakasan, S., Chinn, I. K., Satter, L. F., Freeman, A. F., et al. (2026) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.10.026 · Cited by 35
Self-citationJanyst, M., Kaleta, B., Janyst, K., Zagożdżon, R., Kozłowska, E., & Lasek, W. (2020) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-020-00582-6 · Cited by 26
High purity and yield of natural Tregs from cord blood using a single step selection method
Figueroa-Tentori, D., Querol, S., Dodi, I. A., Madrigal, J. A., & Duggleby, R. C. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.09.019 · Cited by 21
Ismail, I. H., Boyle, R. J., Mah, L., Licciardi, P. V., & Tang, M. L. K. (2014) · Pediatric Allergy and Immunology · doi:10.1111/pai.12303 · Cited by 21
Identification of CD4+CD25high Foxp3+ T cells in ovine peripheral blood
Rocchi, M., Wattegedera, S. R., Frew, D., Entrican, G., Huntley, J. F., & McNeilly, T. N. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.07.010 · Cited by 21
Regulatory T cells in autologous stem cell transplantation for autoimmune disease
van Wijk, F., Roord, S. T. A., Vastert, S. J., de Kleer, I., Wulffraat, N. M., & Prakken, B. J. (2008) · Autoimmunity · doi:10.1080/08916930802200182 · Cited by 21
“[37] Wang J, Ioan-Facsinay A, van der Voort EI, et al.”
BackgroundNovel Immunotherapies for Autoimmune Hepatitis
Cassim, S., Bilodeau, M., Vincent, C., & Lapierre, P. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00008 · Cited by 26
“These contradictory reports may stem in part from difficulties to effectively identify human Tregs based on the markers such as CD25 and FoxP3 that can be transiently expressed by activated effector T cells (59).”
BackgroundLisowska, K. A., Dębska-Ślizień, A. M., Jasiulewicz, A., Bryl, E., & Witkowski, J. M. (2013) · Inflammation Research · doi:10.1007/s00011-013-0679-z · Cited by 21
“Identification of regulatory T cells is still problematic, especially after discovering that transcription factor FoxP3 (forkhead box P3), currently the most reliable marker for Tregs, is also induced upon activation of CD4 T cells [11].”
BackgroundHarnessing dendritic cells for the induction of transplantation tolerance
Silk, K. M., & Fairchild, P. J. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32832c6a1d · Cited by 21
Soldevila, B., Alonso, N., Martínez-Arconada, M. J., Morillas, R. M., Planas, R., Sanmartı́, A., & Martínez-Cáceres, E. M. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01317.x · Cited by 21
Regulatory T Cells in the Immunodiagnosis and Outcome of Kidney Allograft Rejection
Franzese, O., Mascali, A., Capria, A., Castagnola, V., Paganizza, L., & Daniele, N. D. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/852395 · Cited by 21
“Indeed the transient expression of Foxp3 can be a normal consequence of T cell activation without the acquisition of a Treg phenotype [52].”
BackgroundMonitoring of the Immune Dysfunction in Cancer Patients
Santegoets, S. J. A. M., Welters, M. J. P., & van der Burg, S. (2016) · Vaccines · doi:10.3390/vaccines4030029 · Cited by 23
“While in mice, specific markers for MDSC and Treg detection have been identified (Gr-1 and its isoforms Ly6C and Ly6G for MDSC and Foxp3 for Treg detection), in humans, the identification of these cells is more complex, as Gr-1 is not expressed on human leukocytes [115], and Foxp3 can also be expressed on activated no…”
BackgroundThe Importance of the Transcription Factor Foxp3 in the Development of Primary Immunodeficiencies
Mertowska, P., Mertowski, S., Podgajna, M., & Grywalska, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040947 · Cited by 21
Dominguez‐Villar, M., Fernandez-Ponce, C. M., Muñoz-Suano, A., Gomez, E., Rodríguez‐Iglesias, M., & Garcia-Cozar, F. J. (2012) · Clinical Science · doi:10.1042/cs20110631 · Cited by 21
Participation of T regulatory cells in equine recurrent airway obstruction
Henríquez, C., Pérez, B., Morales, N., Sarmiento, J., Carrasco, C., Morán, G., & Folch, H. (2014) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2013.12.005 · Cited by 20
“This generalized increase of Foxp3 positive cells within the CD4+ population may be due to transient expression of Foxp3 in naive T cells (Wang et al., 2007) or the generation of iTregs by the inflammatory milieu in the lung (Xu et al.”
BackgroundBernard, F., Romano, A., & Granel, B. (2009) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.03.364 · Cited by 20
Elmaraghy, N., Ghaly, M. S., Dessouki, O., Nasef, S. I., & Metwally, L. A. (2017) · Archives of Medical Science · doi:10.5114/aoms.2016.63597 · Cited by 20
IPEX as a Consequence of Alternatively Spliced FOXP3
Mailer, R. K. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.594375 · Cited by 25
CD8+ regulatory T cells—A distinct T-cell lineage or a transient T-cell phenotype?
Aandahl, E. M., Torgersen, K. M., & Taskén, K. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.291 · Cited by 20
Budna, J., Kaczmarek, M., Kolecka-Bednarczyk, A., Spychalski, Ł., Zawierucha, P., Goździk-Spychalska, J., Nowicki, M. O., Batura‐Gabryel, H., & Sikora, J. (2018) · Journal of Immunology Research · doi:10.1155/2018/9876014 · Cited by 20
“However, its expression is not a unique feature of this subpopulation, since it can be found on CD4 CD25 effector T cells [7], suppressor Tr1 and Th3 cells [8], or cancer cells [9].”
Backgroundγδ T cells are associated with inflammation and immunopathogenesis of leprosy reactions
Saini, C., Tarique, M., Ramesh, V., Khanna, N., & Sharma, A. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.07.005 · Cited by 22
Nickle, R. A., DeOca, K. B., Garcia, B. L., & Mannie, M. D. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104664 · Cited by 21
Bojanić, I., Worel, N., Pacini, C. P., Stary, G., Piekarska, A., Flinn, A. M., Schell, K. J., Gennery, A. R., Knobler, R., de Lacerda, J. F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1086006 · Cited by 20
Expansion of CD4+ CD25+ FoxP3+ regulatory T cells in chronic hepatitis C virus infection.
Hashempoor, T., Bamdad, T., Merat, S., Janzamin, E., Nemati, L., Jabbari, H., Sharifi, A., & Zamini, H. (2010) · PubMed · doi:10.22034/iji.2010.17054 · Cited by 19
In vitro effects of dexamethasone on bovine CD25+CD4+ and CD25−CD4+ cells
Maślanka, T., & JAROSZEWSKI, J. J. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.01.018 · Cited by 17
Sorathia, N., Al-Rubaye, H., & Zal, B. (2019) · European Cardiology Review · doi:10.15420/ecr.2019.9.2 · Cited by 22
Eckerstorfer, P., Novy, M., Burgstaller-Muehlbacher, S., Paster, W., Schiller, H. B., Mayer, H., & Stockinger, H. S. J. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.04.002 · Cited by 19
Sewgobind, V. D. K. D., van der Laan, L. J. W., Kho, M. M. L., Kraaijeveld, R., Korevaar, S. S., Mol, W. M., Weimar, W., & Baan, C. C. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04183.x · Cited by 25
The Phenotypic Markers of CD4+CD25+ T Regulatory Lymphocytes
Lašťovička, J. (2013) · Research in Endocrinology · doi:10.5171/2013.119348 · Cited by 25
Soontararak, S., Ardaum, P., Senarat, N., Yangtara, S., Lekcharoensuk, C., Putchong, I., Kashemsant, N., Vijarnsorn, M., Chow, L., DOW, S. W., et al. (2022) · Animals · doi:10.3390/ani12192717 · Cited by 19
“Previous studies have suggested that the FOXP3 expression was transient by in vitro induction and the activated, nonsuppressive T cells also expressed this marker [42].”
BackgroundAlfaar, A. S., Stürzbecher, L., Diedrichs‐Möhring, M., Lam, M., Roubeix, C., Ritter, J. M., Schumann, K., Annamalai, B., Pompös, I.-M., Rohrer, B., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02620-w · Cited by 19
Impairment of Circulating CD4+CD25+GARP+Regulatory T Cells in Patients with Acute Coronary Syndrome
Meng, K., Zhang, W., Zhong, Y., Mao, X., Lin, Y., Huang, Y., Lang, M., Peng, Y., Zhu, Z., Liu, Y., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358639 · Cited by 19
Prado, C., de Paz, B., López, P., Gómez, J. M. F., Rodríguez‐Carrio, J., & Suárez, A. (2012) · Cytokine · doi:10.1016/j.cyto.2012.08.033 · Cited by 19
Schadenberg, A. W. L., Vastert, S. J., Evens, F. C. M., Kuis, W., van Vught, A. J., Jansen, N. J. G., & Prakken, B. J. (2011) · European Journal of Immunology · doi:10.1002/eji.201040363 · Cited by 20
Sewgobind, V. D. K. D., van der Laan, L. J. W., Kho, M. M. L., Kraaijeveld, R., Korevaar, S. S., van Dam, T., IJzermans, J. N. M., Weimar, W., & Baan, C. C. (2010) · Transplantation · doi:10.1097/tp.0b013e3181c9cc7a · Cited by 18
The Role of Distinct T Cell Subsets in Periodontitis—Studies from Humans and Rodent Models
Okui, T., Aoki‐Nonaka, Y., Nakajima, T. E., & Yamazaki, K. (2014) · Current Oral Health Reports · doi:10.1007/s40496-014-0013-z · Cited by 19
Sadeghi, A., Ullenhag, G. J., Wagenius, G., Tötterman, T. H., & Eriksson, F. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.737020 · Cited by 18
Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy
Payne, K. K. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1213278 · Cited by 20
“While human Tregs do express Foxp3, its expression is not necessarily indicative of suppressive activity of CD4 T cells (Hori, Nomura & Sakaguchi, 2003; Miyara et al., 2009; Wang et al., 2007).”
BackgroundInterleukin 21 inhibits cancer-mediated FOXP3 induction in naïve human CD4 T cells
Kannappan, V., Butcher, K., Trela, M., Nicholl, I. D., Wang, W., & Attridge, K. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1970-6 · Cited by 19
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation
Mancusi, A., Piccinelli, S., Velardi, A., & Pierini, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02901 · Cited by 22
“FOXP3 is a transcription factor of the forkhead winged helix family and is the lineage marker for both mouse and human Tregs (20–25), although human Tcons can express low levels of FOXP3 after activation (26, 27).”
BackgroundHicheri, Y., Bouchekioua, A., Hamel, Y., Henry, A., Rouard, H., Pautas, C., Beaumont, J.-L., Kuentz, M., Cordonnier, C., Cohen, J. L., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318184908d · Cited by 18
“56 NS Follow-up after DLI, mean (range), mo 20 (3-61) 17 31 NS 13 41 0.”
Barczyk, A., Pierzchała, W., Caramori, G., Wiaderkiewicz, R., Kaminski, M., Barnes, P. J., & Adcock, I. M. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-22 · Cited by 20
The state of T cells before cryopreservation: Effects on post-thaw proliferation and function
Luo, Y., Wang, P., Liu, H., Zhu, Z., Li, C., & Gao, Y. (2017) · Cryobiology · doi:10.1016/j.cryobiol.2017.08.008 · Cited by 18
Rindsjö, E., Joerink, M., Johansson, C., Bremme, K., Malmström, V., & Scheynius, A. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02266.x · Cited by 18
“FOXP3 is considered the most specific marker for regulatory T cells in humans, but still, FOXP3 can be transiently induced in nonregulatory T cells and does not always predict suppressive function (20).”
Bernardo, D., Al-Hassi, H. O., Mann, E. R., Tee, D., Murugananthan, A., Peake, S. T. C., Hart, A. L., & Knight, S. C. (2012) · Human Immunology · doi:10.1016/j.humimm.2011.12.017 · Cited by 17
Thymus-derived hormonal and cellular control of cancer
Savino, W., & Lepletier, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1168186 · Cited by 19
“Theories attempting to explain the association between autoimmune disorders and thymomas are based on the failure of positive and negative selection of thymocytes, the absence of regulatory mechanisms provided by AIRE, and on a Treg-poor environment in the neoplastic thymus (115).”
BackgroundInfluentialAnalysis of the Transcriptional Program of Developing Induced Regulatory T Cells
Prots, I., Skapenko, A., Lipsky, P. E., & Schulze‐Koops, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016913 · Cited by 16
“Foxp3 is expressed in human T cells upon activation without mediating a regulatory capacity [45].”
Antiga, E., Quaglino, P., Pierini, I., Volpi, W., Lami, G., Bianchi, B., BIANCO, E. D., Renzi, D., Baroni, G., Novelli, M., et al. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.11.003 · Cited by 17
“Our study has some limitations, including the fact that FOXP3, although still considered the most specific marker for Tregs, can be transiently expressed on activated T cells [32].”
BackgroundDaniel, V., Sadeghi, M., Wang, H., & Opelz, G. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.09.010 · Cited by 20
T‐Cell Immunopeptidomes Reveal Cell Subtype Surface Markers Derived From Intracellular Proteins
Olsson, N., Schultz, L. M., Zhang, L., Khodadoust, M. S., Narayan, R., Czerwinski, D. K., Levy, R., & Elias, J. E. (2018) · PROTEOMICS · doi:10.1002/pmic.201700410 · Cited by 18
Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells
Mannie, M. D., DeOca, K. B., Bastian, A. G., & Moorman, C. D. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104173 · Cited by 20
Dar, S. A., Das, S., Ramachandran, V. G., Bhattacharya, S. N., Mustafa, M., Banerjee, B. D., & Verma, P. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2011.642103 · Cited by 17
“However, as: (1) CD25 and FoxP3 expression are concurrently induced upon lymphocyte activation with various stimuli (Allan et al., 2007; Pillai et al., 2007; Wang et al., 2007); (2) human CD4 lymphocytes with the highest CD25 expression levels are regarded to represent T reg (in contrast to CD4 cells with intermediate…”
BackgroundFoxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response
Sun, L., Wu, J., & Yi, S. (2011) · Transplant Immunology · doi:10.1016/j.trim.2011.10.005 · Cited by 20
Heterogeneous Inflammatory Changes in Liver Graft Recipients With Normal Biochemistry
Gelson, W., Hoare, M., Unitt, E., Palmer, C., Gibbs, P., Coleman, N., Davies, S. E., & Alexander, G. (2010) · Transplantation · doi:10.1097/tp.0b013e3181c96b32 · Cited by 17
“Evidence that Foxp3 may not be specific for T-regulatory cells in humans is provided by the observation that a nonregulatory (Th1 type) subset of activated cells express Foxp3 transiently (29, 30) when PBMCs are stimulated in vitro.”
BackgroundSilva, H. M., Moraes‐Vieira, P. M., Costa, P., Pimentel, B. M. S., Moro, A. M., Kalil, J. E., Maranhão, A. Q., Coelho, V. P. C. V., & Brígido, M. M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.06.009 · Cited by 18
Anastasopoulou, E. A., Voutsas, I. F., Papamichail, M., Baxevanis, C. N., & Perez, S. A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1178439 · Cited by 18
Detection of Foxp3+ Cells on Biopsies of Kidney Transplants With Early Acute Rejection
Martin, L., de la Vega, M. F., Bocrie, O., Harzallah, A., Justrabo, E., Rifle, G., & Mousson, C. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.08.037 · Cited by 17
Regulatory T Cells: Therapeutic Opportunities in Uveitis
Lee, A. Y., & Foulsham, W. (2022) · Frontiers in Ophthalmology · doi:10.3389/fopht.2022.901144 · Cited by 15
Monitoring regulatory T cells as a prognostic marker in lung transplantation
Khan, M. A., Lau, C. L., & Krupnick, A. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235889 · Cited by 17
“Other clinical studies also demonstrated T cell subsets within the lung and reported that patients with acute rejection had lower CD3 + cells that expressed FOXP3 compared to non-rejectors (97, 104, 111, 112).”
ResultMolecular Regulation ofCellular Immunity by FOXP3
McMurchy, A. N., Nunzio, S. D., Roncarolo, M. G., Bacchetta, R., & Levings, M. K. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1599-3_3 · Cited by 19
Differential homeostatic dynamics of human regulatory T-cell subsets following neonatal thymectomy
Schadenberg, A. W. L., van den Broek, T., Siemelink, M. A., Algra, S. O., de Jong, P. R., Jansen, N. J. G., Prakken, B. J., & van Wijk, F. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.08.030 · Cited by 16
“The relative increase in the heterogeneous and nonsuppressive CD45RO(1)FOXP3low population (fraction III) may be a reflection of activation-induced transient upregulation of FOXP3, as has been shown in vitro.(7) Absolute numbers of both ‘‘true’’ Treg cell fractions decreased marginally, though not significantly (Fig 2…”
Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes
Li, C., Baaten, B. J. G., & Bradley, L. M. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr040 · Cited by 17
“For instance, in mouse CD4+ T cells FoxP3 expression is exclusively Treg-specific, whereas in human CD4+ T cells, FOXP3 can be transiently expressed during activation and does not necessarily confer suppressor function (Wang et al., 2007).”
Nowatzky, J., Stagnar, C., & Manches, O. (2019) · Cytometry Part A · doi:10.1002/cyto.a.23704 · Cited by 16
“Additional complexity is added by the intra-nuclear expression of the Treg lineage marker, FoxP3, its upregulation in activated human non-Treg effector cells, and its constitutive low-level expression in a distinct population of CD4 cytokine-secreting nonsuppressive cells (1,2).”
BackgroundLee, J. G., Jaeger, K. E., Seki, Y., Lim, Y. W., Cunha, C., Vuchkovska, A., Nelson, A. J., Nikolai-Yogerst, A., Kim, D., Nishimura, M. I., et al. (2021) · Immunology · doi:10.1111/imm.13316 · Cited by 17
Characterization of Naturally Occurring CD4+CD25+ Regulatory T Cells in Rhesus Monkeys
Haanstra, K. G., van der Maas, M., Hart, B. A. ‘., & Jonker, M. (2008) · Transplantation · doi:10.1097/tp.0b013e31816b15b9 · Cited by 16
Xu, T., Jie-zhen, L., & An, H. (2017) · Oncotarget · doi:10.18632/oncotarget.22606 · Cited by 18
“Moreover, CD127 is not utilized as a negative marker for Treg, and not every FoxP3+ human Treg displays functionally suppressive property [29].”
BackgroundT cell alterations and lymphoid neogenesis favoring autoimmunity in Wegener's granulomatosis
Lamprecht, P., Gross, W. L., & Kabelitz, D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22693 · Cited by 16
A sensitive protocol for FOXP3 epigenetic analysis in scarce human samples
Spreafico, R., Rossetti, M., van den Broek, T., Jansen, N. J. G., Zhang, H., Moshref, M., Prakken, B., van Loosdregt, J., van Wijk, F., & Albani, S. (2014) · European Journal of Immunology · doi:10.1002/eji.201444627 · Cited by 15
Activated protein C modulates T-cell metabolism and epigenetic FOXP3 induction via α-ketoglutarate
Gupta, D., Elwakiel, A., Ranjan, S., Pandey, M. K., Krishnan, S., Ambreen, S., Henschler, R., Rana, R., Keller, M., Ceglarek, U., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010083 · Cited by 16
Low-dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation?
Amini, L., Kaeda, J., Weber, O., & Reinke, P. (2024) · Transplantation · doi:10.1097/tp.0000000000004866 · Cited by 17
CD137-expressing regulatory T cells in cancer and autoimmune diseases
Lee, K. Y., Mei, Y., Liu, H., & Schwarz, H. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.12.010 · Cited by 15
Watanabe, S., Ide, N., Ogawara, H., Yokohama, A., Mitsui, T., Handa, H., Koiso, H., Tsukamoto, N., Saitoh, T., & Murakami, H. (2014) · Acta Haematologica · doi:10.1159/000362356 · Cited by 15
Singh, M., Basu, S., Camell, C. D., Couturier, J. P., Nudelman, R. J., Medina, M. Á., Rodgers, J. R., & Lewis, D. E. (2008) · European Journal of Immunology · doi:10.1002/eji.200737929 · Cited by 17
Comparison of circulating and intratumoral regulatory T cells in patients with renal cell carcinoma
Gati, A., Amal, G., Raja, M., Derouiche, A., Chebil, M., & Amel, B. A. E. (2015) · Tumor Biology · doi:10.1007/s13277-014-3012-8 · Cited by 17
Tabares, P., Berr, S., Langenhorst, D., Sawitzki, B., ten Berge, I. J. M., Tony, H., & Hünig, T. (2017) · European Journal of Immunology · doi:10.1002/eji.201747244 · Cited by 16
Liu, C., Xu, L., Xia, C.-S., Long, Y., Liu, C., Lu, S., & Song, Y. (2019) · Hepatology Research · doi:10.1111/hepr.13472 · Cited by 15
Traitor or warrior–Treg cells sneaking into the lesions of psoriatic arthritis
Liu, Y., Jarjour, W. N., Olsen, N. J., & Zheng, S. G. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108425 · Cited by 15
Teng, C., Li, T., Wang, T., Liao, D.-C., Wen, Y.-H., Wu, T., Wang, J., Wu, H., Shyu, W., Su, I., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80935-5 · Cited by 17
Self-citationLibetta, C., Esposito, P. B., Gregorini, M., Margiotta, E., Martinelli, C., Borettaz, I., Canevari, M., Rampino, T., Ticozzelli, E., Abelli, M., et al. (2015) · Transplant Immunology · doi:10.1016/j.trim.2015.07.005 · Cited by 15
A flow cytometry based assay for the enumeration of regulatory T cells in whole blood
Hardy, M. Y., Vari, F., Rossetti, T. R., Hart, D. N. J., & Prue, R. L. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.07.004 · Cited by 16
Şahın, E., & Sahin, M. A. (2018) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000247 · Cited by 15
T-regulatory cells infected with feline immunodeficiency virus up-regulate programmed death-1 (PD-1)
Achleitner, A., Clark, M. E., & Bienzle, D. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.06.009 · Cited by 15
Nellore, A., Liu, B., Patsoukis, N., Boussiotis, V. A., & Li, L. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.02.015 · Cited by 14
“In human T cells Foxp3 is expressed early after stimulation and under these conditions is not an indicator of Treg development but rather serves as an activation marker [27,28].”
BackgroundKeoshkerian, E., Hunter, M., Cameron, B., Nguyen, N., Sugden, P. B., Bull, R. A., Zekry, A., Maher, L., Seddiki, N., Zaunders, J., et al. (2016) · Journal of Viral Hepatitis · doi:10.1111/jvh.12576 · Cited by 19
Immune checkpoint failures in inflammatory myopathies: An overview
Herbelet, S., & Bleecker, J. D. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.026 · Cited by 14
Dolina, J. S., Lee, J., Griswold, R. Q., Labarta-Bajo, L., Kannan, S., Greenbaum, J., Idrissi, N. B. E., Pont, M. J., Croft, M., & Schoenberger, S. P. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.040 · Cited by 15
Molecular signature of methotrexate response among rheumatoid arthritis patients
Brynedal, B., Yoosuf, N., Ulfarsdottir, T. B., Ziemek, D., Maciejewski, M., Folkersen, L., Westerlind, H., Müller, M., Sahlström, P., Jelinsky, S. A., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1146353 · Cited by 16
“The decreased proportion of IL-21expressing T-cells in non-responding patients could indicate an altered tissue distribution of these cells, or a reduced overall expression of IL21R in T cells specifically.”
BackgroundInfluential
Metadata
- Authors
- Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Toes, René E. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2006-12-21
- Volume
- 37
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984909066
- Cited by
- 1,011
- References
- 43
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 24 · 2023: 29 · 2022: 25 · 2021: 36 · 2020: 39 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 43 · 2015: 47 · 2014: 61 · 2013: 63 · 2012: 69
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, regulatory T cells, CD4+ T cell activation, T cell hyporesponsiveness, CD25, anti-CD3 stimulation, human T cells
- MeSH terms
- Cells, Cultured, Humans, Lymphocyte Activation, Time Factors, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Resting Phase, Cell Cycle, Cytokines, Self Tolerance, Coculture Techniques, Cell Proliferation, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.